NCT03883269View on ClinicalTrials.gov

Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

December 31, 2019

Conditions
Acne Vulgaris
Interventions
DRUG

Erythromycin 4% topical gel formulation

Erythromycin 4% topical gel formulation, BID, 4 weeks

DRUG

Clindamycin 1% topical lotion formulation

Clindamycin 1% topical lotion formulation, BID, 4 weeks

DRUG

70% topical ethanol solution

70% topical ethanol solution, BID, 4 weeks

Trial Locations (1)

2333 CL

RECRUITING

Centre for Human Drug Research, Leiden

All Listed Sponsors
collaborator

Maruho Co., Ltd.

INDUSTRY

lead

Centre for Human Drug Research, Netherlands

OTHER